Saturday, December 10, 2022
HomeHealthcare SecurityAmphista Lands Megadeals to Smash Cancer using Protein Degradation

Amphista Lands Megadeals to Smash Cancer using Protein Degradation

As big pharma companies flock to drugs that destroy harmful proteins, the UK protein degradation specialist Amphista Therapeutics has bagged two landmark collaboration deals with the heavyweights Bristol Myers Squibb and Merck.

Big pharma companies are piling onto biotechs developing…

Source: www.labiotech.euRead more

Must Read

Catholic providers can deny trans care over religious objections: court

Catholic healthcare organizations that receive federal dollars cannot be required to provide or pay for gender-transition procedures if they have religious objections to them,...